William J Chase's Net Worth
$55.8 Million
Who is William J Chase?
William J Chase has an estimated net worth of $55.8 Million. This is based on reported shares across multiple companies, which include AbbVie Inc., and Intellia Therapeutics, Inc..
SEC CIK
William J Chase's CIK is 0001563572
Past Insider Trading and Trends
2013 was William J Chase's most active year for acquiring shares with 8 total transactions. William J Chase's most active month to acquire stocks was the month of January. 2013 was William J Chase's most active year for disposing of shares, totalling 10 transactions. William J Chase's most active month to dispose stocks was the month of January. 2019 saw William J Chase paying a total of $2,045,920.00 for 152,712 shares, this is the most they've acquired in one year. In 2018 William J Chase cashed out on 191,735 shares for a total of $17,071,052.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AbbVie Inc. (ABBV) Snapshot price: $175.005
EVP, Finance & Administration
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.85% | 30.4K |
$67.30 | $2,045,920.00 | 169.55K |
Jun 26
| |||
Form 4
| -16.39% | -27.28K |
$79.41 | -$2,165,987.16 | 139.15K |
Feb 28
| |||
Form 4
| +58.71% | 61.56K |
—
|
—
| 166.43K |
Feb 21
| |||
Form 4
| -36.39% | -60.00K |
$90.00 | -$5,400,000.00 | 104.86K |
Dec 12
| |||
Form 4
| -28.88% | -66.94K |
$71.70 | -$10,831,712.98 | 164.86K |
Feb 28 - Mar 1
| |||
Form 4
| +26.29% | 48.26K |
—
|
—
| 231.8K |
Feb 15
| |||
Form 4
|
—
|
0
|
$46.99 | -$1,406,911.00 | 183.54K |
May 18
| |||
Form 4
| -17.97% | -40.21K |
$62.22 | -$2,501,990.64 | 183.54K |
Feb 28
| |||
Form 4
| +29.81% | 51.38K |
—
|
—
| 223.75K |
Feb 16
| |||
Form 4
|
—
|
0
|
$43.24 | -$210,540.00 | 172.37K |
Dec 2
| |||
Form 4
| -20.94% | -45.66K |
$56.00 | -$2,556,848.00 | 172.37K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| -7.82% | -18.49K |
$60.51 | -$1,118,911.48 | 218.03K |
Feb 27 - Feb 28
| |||
Form 4
| +31.05% | 56.04K |
—
|
—
| 236.52K |
Feb 19
| |||
Form 4
|
—
|
0
|
$46.04 | -$373,159.02 | 180.07K |
Dec 22
| |||
Form 4
| -7.13% | -13.82K |
$51.43 | -$710,766.10 | 180.07K |
Feb 28 - Mar 3
| |||
Form 4
| +38.37% | 53.77K |
—
|
—
| 193.89K |
Feb 20
| |||
Form 4
| +1.06% | 1.46K |
$44.47 | -$70,460.12 | 140.12K |
Dec 19
| |||
Form 4
| -3.65% | -5.26K |
$36.73 | -$193,199.80 | 138.66K |
Feb 28
| |||
Form 4
| +59.68% | 53.79K |
$37.58 | -$109,432.96 | 143.92K |
Feb 14 - Feb 19
| |||
Form 4
| +0.42% | 379 |
$34.67 | -$8,468.63 | 90.13K |
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.68% | 1.67K |
—
|
—
| 18.96K |
Jun 14
| |||
Form 4
| +154.16% | 10.48K |
—
|
—
| 17.28K |
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||